Daily blog desk

Source-linked Type 1 diabetes articles, generated from the live feed.

This is the public face for ongoing content: daily briefings, device safety watches, trial roundups, research watches, and evidence-label explainers. Updated from the same source pipeline that powers the feed.

Research WatchDaily BriefingClinical TrialsDevice SafetyEditorial Policy

Research Watch/October 18, 2026/3 min read

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

Read today's brief

Source-backed article

Ross Marklein, Ph.D., a post-doctoral research fellow at FDA, examines images of stem cells in an FDA laboratory on the National Institutes of Health campus in

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 17, 2026 / 12 sources

Flat lay of diabetes awareness concept with glucose meter, insulin syringes, sugar cubes, and donut.

Daily Briefing

October 16, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 16, 2026 / 10 sources

Heba Degheidy, M.D., Ph.D., a visiting research associate at FDA, works with stem cell samples in an FDA laboratory on the National Institutes of Health campus

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 16, 2026 / 8 sources

Induced Pluripotent Stem Cells of Huntington's Disease

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 16, 2026 / 12 sources

Woman holding an insulin pen, showcasing healthcare and diabetes management in a modern setting.

Daily Briefing

October 15, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 15, 2026 / 10 sources

Single Photon Emission Computed Tomography (SPECT) with circular containment tube at biosafety level 4 (BSL-4) laboratory of the NIAID Integrated Research Facil

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 15, 2026 / 9 sources

Magnetic Resonance Imaging (MRI) with circular containment tube at biosafety level 4 (BSL-4) laboratory of the NIAID Integrated Research Facility (IRF) in Frede

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 15, 2026 / 12 sources

Diabetic Type 1 adult man with insulin pump and CGM sensor

Daily Briefing

October 14, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 14, 2026 / 10 sources

Doctor in white coat checking patient chart in hospital room with medical equipment.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 14, 2026 / 9 sources

Laboratory technician working with a cell

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 14, 2026 / 12 sources

Symbolic image of diabetes prevention message with pineapple and insulin syringes.

Daily Briefing

October 13, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 13, 2026 / 10 sources

Healthcare professional checks temperature with digital thermometer during patient consultation in a medical office undefined

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 13, 2026 / 10 sources

Senior researcher working with a microscope in a laboratory setting, assisted by a colleague.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 13, 2026 / 12 sources

Two female scientists conducting research with microscope in a laboratory setting.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 12, 2026 / 12 sources

Close-up of a glucometer reading 95 mg/dl with a lancing device, ideal for diabetes and healthcare imagery.

Daily Briefing

October 11, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 11, 2026 / 10 sources

A female scientist uses a microscope in a laboratory, focusing on research and analysis.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 11, 2026 / 12 sources

Artistic depiction of red blood cells on a white background, emphasizing medical concepts.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 10, 2026 / 12 sources

Top view of lancets for blood glucose meter placed near glucometer and letter board with World Diabetes Day inscription

Daily Briefing

October 9, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 9, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

October 9, 2026 / 10 sources

Doctor in consultation with patient at a medical clinic, discussing treatment options.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 9, 2026 / 7 sources

Detailed view of a microscope in a laboratory used in scientific research.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 9, 2026 / 12 sources

High Blood Sugar Readings on Glucose Test Monitoring device

Daily Briefing

October 8, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 8, 2026 / 10 sources

Vaccine research center attached to a Kabul hospital in the 1960s. Original caption: "A laboratory at the Vaccine Research Center."

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 8, 2026 / 10 sources

Close-up of stained plant cells in onion root under microscope.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 8, 2026 / 12 sources

Close-up of a woman's hands holding insulin pens. Perfect for health and diabetes-related content.

Daily Briefing

October 7, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 7, 2026 / 10 sources

A healthcare professional administers an injection to an elderly patient in a hospital setting.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 7, 2026 / 10 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 7, 2026 / 12 sources

A comprehensive flat lay of diabetes management tools including a glucose meter and instructional flyers.

Daily Briefing

October 6, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 6, 2026 / 10 sources

British medics help earthquake-hit hospital in Kathmandu, Nepal

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 6, 2026 / 10 sources

A dense cluster of red blood cells floating in a fluid medium

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 6, 2026 / 12 sources

Researchers conducting a scientific experiment with a syringe and petri dish in a lab setting.

Daily Briefing

October 5, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 5, 2026 / 10 sources

A healthcare professional in gloves provides treatment to a patient in a medical setting.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 5, 2026 / 10 sources

Female scientist using a microscope in a laboratory environment, focusing on research.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 5, 2026 / 12 sources

A cluster of translucent purple cells with glowing pink nuclei on a purple background

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 4, 2026 / 12 sources

A series of microscopes on a lab table, ideal for scientific research and education.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 3, 2026 / 12 sources

A blood glucose meter with a lancing device and test strips on white

Daily Briefing

October 2, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 2, 2026 / 10 sources

A digital glucometer and lancing device on a wooden surface indicating high blood glucose level.

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

October 2, 2026 / 10 sources

Healthcare professional reviews medical form during patient consultation in a clinic setting.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

October 2, 2026 / 6 sources

Doctor checking patient's vitals in a clinical setting for health consultation.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 2, 2026 / 10 sources

Two scientists in a lab examining samples with a microscope. Focus on scientific research and discovery.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 2, 2026 / 12 sources

A Blood-Glucose-Powered Metabolic Fuel Cell for Self-Sufficient Bioelectronics

Daily Briefing

October 1, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

October 1, 2026 / 10 sources

File:Blood Pressure And Blood Glucose Test - Health Check-up Camp - NCSM - Salt Lake City - Kolkata 2017-06-21 2950.JPG

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

October 1, 2026 / 10 sources

A cluster of medical syringes with blue fluid, ideal for healthcare and vaccination themes.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

October 1, 2026 / 6 sources

Khaschuvate Complex of District Hospital Medical Laboratory 01 (YDS 0551)

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

October 1, 2026 / 8 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

October 1, 2026 / 12 sources

Medical research setup featuring anatomical models, x-rays, and a textbook, ideal for educational purposes.

Daily Briefing

September 30, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 30, 2026 / 10 sources

File:Blood Pressure And Blood Glucose Test - Health Check-up Camp - NCSM - Salt Lake City - Kolkata 2017-06-21 2947.JPG

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 30, 2026 / 10 sources

Flat lay of blood pressure monitor, pills, and ECG printout for heart health theme.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 30, 2026 / 6 sources

Pensive man nurse in blue uniform standing and demonstrating diagnosis to serious African American female patient in hallway of hospital in daytime

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 30, 2026 / 10 sources

Close-up of labeled blood collection tubes in a laboratory with red, purple, and green caps.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 30, 2026 / 12 sources

Insulin pen and its packaging are shown.

Daily Briefing

September 29, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 29, 2026 / 10 sources

High Blood Sugar glucose over 200mg Test Results Readings Meter, 1/2015 by Mike Mozart of TheToyChannel and JeepersMedia on YouTube #High #Blood #Sugar #Glucose

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 29, 2026 / 10 sources

Flat lay of diabetes tools, green apple, almonds, and notebook for health planning.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 29, 2026 / 6 sources

Unrecognizable man wearing medical uniform with stethoscope and pens standing in hospital with crossed arms during work in day time

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 29, 2026 / 10 sources

Female scientist working with test tubes and microscope in a laboratory.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 29, 2026 / 12 sources

Close-up of a researcher using tweezers to work with a petri dish in a lab setting.

Daily Briefing

September 28, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 28, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 28, 2026 / 10 sources

Elderly man in a gym stretching with a fitness coach, promoting a healthy lifestyle.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 28, 2026 / 6 sources

Nurse attends to patient with doctor observing

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 28, 2026 / 10 sources

Scientific Research Institute of Lung Diseases of the Ministry of Health of the Republic of Azerbaijan

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 28, 2026 / 12 sources

Researchers in a lab examining test tubes with colored liquids for experiments.

Daily Briefing

September 27, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 27, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 27, 2026 / 10 sources

Close-up of a syringe and medical gloves on a flat surface, showcasing healthcare tools.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 27, 2026 / 6 sources

Medical professional wearing gloves preparing patient for blood draw using a tourniquet.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 27, 2026 / 10 sources

Researchers using a microscope and taking notes in a modern lab.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 27, 2026 / 12 sources

Laboratory scientist conducts an experiment with a Rotary evaporator

Daily Briefing

September 26, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 26, 2026 / 10 sources

person using disposable syringe put specimen on blue and white glucose meter

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 26, 2026 / 10 sources

Flat lay image of healthcare essentials including a blood pressure monitor, pills, and eyeglasses on a white surface.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 26, 2026 / 6 sources

A patient is reflected in a sphygmomanometer during a medical appointment, highlighting the focus on healthcare.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 26, 2026 / 10 sources

A female scientist in a lab coat examines samples under a microscope for research.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 26, 2026 / 12 sources

File:West Nile Vaccine Research in BSL-3 Lab.jpg

Daily Briefing

September 25, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 25, 2026 / 10 sources

A blue insulin pen rests on a white surface

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 25, 2026 / 10 sources

the word mental health spelled with scrabbles next to a green leaf

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 25, 2026 / 6 sources

A modern hospital room featuring advanced medical equipment with digital displays.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 25, 2026 / 9 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 25, 2026 / 12 sources

File:Glasgow clinical research facility.png

Daily Briefing

September 24, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 24, 2026 / 10 sources

Bottle of dextrotabs for glucose and glucose

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 24, 2026 / 10 sources

Adult female using a medical weighing scale in a healthcare setting.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 24, 2026 / 6 sources

A doctor performs an eye examination on a patient in a clinical setting.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 24, 2026 / 10 sources

Army scientists energize battery research

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 24, 2026 / 12 sources

Daily Briefing

September 23, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 23, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 23, 2026 / 10 sources

Syringe and vaccine vials arranged on gray surface, symbolizing healthcare and immunization.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 23, 2026 / 6 sources

Nurse uses digital tablet for patient consultation and diagnosis in a clinical setting.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 23, 2026 / 10 sources

Portrait, microscope, laboratory, test tube, scale, burette Fortepan 7166

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 23, 2026 / 12 sources

Detailed view of a semaglutide injection pen, commonly used for diabetes treatment, on a plain background.

Daily Briefing

September 22, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 22, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 22, 2026 / 10 sources

Detailed close-up of vibrant blue gel capsules symbolizing medical and healthcare treatments.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 22, 2026 / 6 sources

A blood bag with a drip chamber hanging in a clinical setting

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 22, 2026 / 9 sources

A scientist carefully examining samples using a microscope in a modern laboratory setting.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 22, 2026 / 12 sources

Scientists from South Africa training on mRNA Vaccine Production at the NIAID Vaccine Research Center

Daily Briefing

September 21, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 21, 2026 / 10 sources

A yellow medical sensor attached to a person's arm

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 21, 2026 / 10 sources

Colorful vegan salads featuring fresh vegetables in close-up for healthy eating inspiration.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 21, 2026 / 6 sources

Duke Clinical Research Institute, Durham, North Carolina

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 21, 2026 / 10 sources

Detailed view of a scientist operating a microscope in a laboratory setting.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 21, 2026 / 12 sources

Naval Medical Research Center labs support Operation United Assistance

Daily Briefing

September 20, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 20, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 20, 2026 / 10 sources

Refreshing breakfast arrangement with fruit, nuts, and tea for a healthy start.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 20, 2026 / 6 sources

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 20, 2026 / 10 sources

Barbara McClintock (1902-1992), Department of Genetics, Carnegie Institution at Cold Spring Harbor, New York, shown in her laboratory. This photograph was distr

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 20, 2026 / 12 sources

A young female scientist with curly hair in a lab coat working in a laboratory setting.

Daily Briefing

September 19, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 19, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 19, 2026 / 10 sources

Black drongo (Dicrurus macrocercus) with it's healthy meal, Padma river, Rajshahi

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 19, 2026 / 6 sources

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 19, 2026 / 10 sources

A scientist works with a microscope in a bright, modern lab setting, wearing a lab coat.

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 19, 2026 / 12 sources

Daily Briefing

September 18, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 18, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 18, 2026 / 10 sources

Bunches of healthy dill and fresh lettuce placed near heap of green onions on stall in grocery market during harvest season

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 18, 2026 / 6 sources

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 18, 2026 / 10 sources

a microscope with a microscope attached to it

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 18, 2026 / 12 sources

Detailed view of laboratory glass vials held by a clamp with red handles, ideal for science stock images.

Daily Briefing

September 17, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 17, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 17, 2026 / 10 sources

Women exercising with resistance bands in a well-lit rustic studio, promoting fitness and health.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 17, 2026 / 6 sources

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 17, 2026 / 10 sources

A Meiji Techno microscope with multiple objective lenses above a black stage

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 17, 2026 / 12 sources

A scientist in a white lab coat using a laptop in a laboratory

Daily Briefing

September 16, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 16, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 16, 2026 / 10 sources

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 16, 2026 / 6 sources

Doctor examining patient's eyes with equipment

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 16, 2026 / 10 sources

20160926 Clinical Research Centre Malmo 0058 (29343224923)

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 16, 2026 / 12 sources

Daily Briefing

September 15, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 15, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 15, 2026 / 10 sources

Close-up of a healthcare professional measuring an infant using a medical ruler.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 15, 2026 / 6 sources

A medical professional checking patient reports with a clipboard in an office setting.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 15, 2026 / 10 sources

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 15, 2026 / 12 sources

File:Dominique Wilkins speaks to an attentive group at the Diabetes Living Room in Philadelphia.jpg

Daily Briefing

September 14, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

September 14, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

September 14, 2026 / 10 sources

A female doctor uses a stethoscope to listen to a young boy's heartbeat, conducting a health check outdoors.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

September 14, 2026 / 6 sources

A doctor holds a pill bottle while consulting with an elderly patient. A stethoscope and prescriptions are visible.

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

September 14, 2026 / 10 sources

Prorew medical laboratory and Diagnostics

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

September 14, 2026 / 12 sources

European Molecular Biology Laboratory (EMBL) - July 2022 10

Daily Briefing

July 1, 2026 Type 1 diabetes briefing: trials, device safety, and research signals

A daily Type1Cure briefing built from current official and public source pulls, with each item labeled by source, evidence class, and family relevance.

July 1, 2026 / 10 sources

Device Safety

Type 1 diabetes device safety watch: latest FDA recall signals families should review

A focused safety brief from the current FDA device recall lane, prioritizing CGM, pump, insulin-delivery, glucose-monitoring, and related diabetes-device records.

July 1, 2026 / 10 sources

Two adults cooking fresh vegetables on a stove, preparing a healthy meal in a modern kitchen.

Editorial Policy

How Type1Cure labels Type 1 diabetes evidence before it becomes a headline

The editorial model behind Type1Cure: rank sources by evidence strength, preserve source links, separate sponsor influence, and avoid miracle-cure language.

July 1, 2026 / 6 sources

Patients To Benefit From New Technology (40779081165)

Clinical Trials

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

July 1, 2026 / 10 sources

Microhaematocrit Centrifuge; from a medical laboratory in Abuja, Nigeria

Research Watch

Type 1 diabetes research watch: recent papers and DOI records worth sorting

A daily research brief that separates literature discovery from clinical meaning, so promising headlines do not get mistaken for proven care changes.

July 1, 2026 / 12 sources